GLP-1 medications slow stomach emptying intentionally, but clinical trials and post-market data show that confirmed gastroparesis diagnoses are extremely rare
Nov 05, 2025, 08:15 ET Post hoc analyses include data showing investigational oral semaglutide 25 mg use was associated with improvements in blood sugar control and cardiovascular (CV) risk factors across multiple categories of weight loss 1 Another analysis detailed an indirect trial comparison between oral semaglutide 25 mg and the currently available injectable form, showing comparable efficacy 2 In two additional analyses, oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively 3,4 PLAINSBORO, N.J

Thyroid Cancer Risk: Human Studies Shared Decision-Making: The Patient With Cancer Who Is Also Receiving a GLP-1 RA It is important to discuss these potential adverse events (such as excess nausea and vomiting, nutritional deficiencies, changes in bioavailability of oral chemotherapies) with the patient newly diagnosed with cancer who is receiving a GLP-1 RA before initiating chemotherapy to determine the optimal treatment plan
Manage Stress If you regularly experience high levels of stress, not only will you find it difficult to be intimate with your partner, but youll also diminish the levels of glutathione your cells are working with